You are here

  • Home
  • Archive
  • Volume 59, Issue 6
  • Reply to Egervari et al “IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma”

Article Text

Article menu
Download PDFPDF
Correspondence
Reply to Egervari et al “IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma”
  1. B Dunne
  1. Central Pathology Laboratory, St James’s Hospital, Dublin 8, Republic of Ireland; barbaradunne@hotmail.com

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    I read with interest a response by K Egervari et al1(this issue, p 665) to the recently published article entitled: “IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma”.2

    As stated in our study, the cost per assay with CBE356 antibody was calculated at …

    View Full Text

    Footnotes

    • Competing interests: None declared.

    Linked Articles